Journal article
Regulatory T cells for tolerance
- Abstract:
-
Regulatory T cells (Tregs) are critical mediators of immune homeostasis and hold significant promise in the quest for transplantation tolerance. Progress has now reached a critical threshold as techniques for production of clinical therapies are optimised and Phase I/II clinical trials are in full swing. Initial safety and efficacy data are being reported, with trials assessing a number of different strategies for the introduction of Treg therapy. It is now more crucial than ever to elucidate...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, ppt, 790.0KB)
-
(Accepted manuscript, pdf, 528.9KB)
-
(Accepted manuscript, pdf, 139.2KB)
-
- Publisher copy:
- 10.1016/j.humimm.2017.12.013
Authors
Funding
European Society for Organ Transplantation
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Human Immunology Journal website
- Volume:
- 79
- Issue:
- 5
- Pages:
- 294-303
- Publication date:
- 2017-12-27
- Acceptance date:
- 2017-12-26
- DOI:
- EISSN:
-
1879-1166
- ISSN:
-
0198-8859
- Pmid:
-
29288698
- Source identifiers:
-
817654
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:817654
- UUID:
-
uuid:3892a760-fc2b-49cf-82a4-2c1b3e2b865d
- Local pid:
- pubs:817654
- Deposit date:
- 2018-11-21
Terms of use
- Copyright holder:
- American Society for Histocompatibility and Immunogenetics
- Copyright date:
- 2017
- Notes:
- Copyright © 2018 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.humimm.2017.12.013
If you are the owner of this record, you can report an update to it here: Report update to this record